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Summary
Asthma is an obstructive airways disease in which smoolh muscle spasm
plays an important role. In most aslhmatic patienls lhis obslruction is reversible
and unique bronchoconstriclor medialors have long been considered lo be
responsible for the muscle spasm and other adverse processes involved. Later,
it was observed that many of these patients respond to lower concentrations of
irÈnled spasmogens and with more profound bronchospasm compaÍed with
healthy individuals. At present, most investigators adhere to the concept that
this hyperresponsiveness (/) is an importanl inherent mechanism in asthma and
(2) is related to local inllammalion. In allergic asthma, IgE-mediated anligen-
antibody responses initiate the release of obstructive and inÍlammatory mediators
and the aclivalion of inÍlammatory cells. On the other hand, inhaled irritants
can fr:rlher damage the shedded airway epithelium and initiate inÍlammatory
repair mechanisms. Both processes involve many cells and mediatoÍs interacthg
in a complex way.
One aspect of asthma, not dealt with in this thesis, is the production and
clearance of mucus. A hyperplasia of gland and goblet cells and shedding
of epithelial cells may contribute to abnormal secretions which can ultimately
lead lo life{fueatening mucus plugging. In an early stage of the disease, the
combination of mucrrs secÍetion and smooth muscle spasm can lead in a
synergistic way to episodes of acule obstruclion.
The rrse of p-adrenoceptor agonists coÍlslitules a ftst-line treatment of
asthmatic patients sufiering from acule airway narorving. Within a few minutes,
airway smooth muscle is relaxed and mucus secretion inhibited, relieving lhe
patient. However, not all patients respond adequately lo this drug. hr this thesis,
the main objective was lo leam in more delail about the factors goveming
p-adrenoceploÍ funclion in non-allergic and allergic aiÍways obslruction. lrye
made use of isolated tissues Íestricting to some extenl the myriad interactive
pÍocesses involved.
Following lhe specific binding of an agonist to its receplor, a pÍocess of
signal transduction is initiated which translates the agonist-receptor interaclion
inlo lhe geneÍation of second messengerc by membrane-bound enzymes. The
p-adrenoceptor is linked with the enzyme adenylyl cyclase which converts ATP
into cyclic AMP, whereas receptors for contractile agonists like acetylcholine,
histamine, and leukotrienes are linked to phospholipase C (phosphoinositidase)
which convens the membrane-derived phospholipid phosphatidylinosilol
4,S-bisphosphate (ppz) into inositol 1,4,5{risphosphate (trs) anO diacylglycerol.
In lhese transduction processes, so-called G-proteins play a pivotal role.
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Transduction syslems mediating opposite cellular responses (causing firnctional
anlagonism) can be linked in different ways. This is apparent ftom lhe many
biochemical steps which are shared and frequently modulated in opposite ways
with reference lo phosphorylation and dephosphorylation of proteirs
(cf Chapter 1). On lhe olher hand, increasing evidence has become available
(e.9. Chaptes 2 and 3) that lransductional events following stimulation of one
receptor may modulale the coupling efficiency of a difierent receplor, a process
denoted'cross-lalk' of receplors.
Clinical experience has shown lhat p-adrenoceptoÍ agonisls become less
effeclive as asthmatic episodes become more severe. In chapters 2 and 3, we
found in guinea-pig lrachea and human small bronchi that hislamine and lfuee
differenl muscarinic receptor agonists decrease the apparenl affinity (pDz) of the
p-agonist isoprenaline for lhe p-adrenoceptor and induce a loss of maximum
relaxation (E-""), which effecls depended both on lhe concentration and on
the type of contraclile agonist used. The four conlraclile agonists showed an
excellenl linear correlalion between their potency to slimulate lhe produclion
of inositol phosphates and lo conlract lhe airway smoolh muscle preparalions.
This indicated lhal the phosphoinositide (PI) pathway is direclly involved in the
pharmacomechanical couplhg of lhe receptoÍs. It was also found that lhe
increases in inositol phosphales production were directly lelaled to the reduclion
of pD2 ànd Ema_< values of isoprenaline. This reduclion was more pronounced
al supramaximal concentralions, i.e. exceeding lhose required for maximal
conlraclion when lhe increases in phosphoinositide melabolism lvere no longer
paralleled by increases in conlraclion. These results clearly suggesled a
functional (presumably causal) relationship between lhe levels of phospho-
inositide melabolism and p-adrenoceplor function in airway smooth muscle.
They may also explain the reduced efficacy of p-adrenoceptor agonists dwing
acule and severe asthmatic episodes.
In allergic aslhma, the local release of corslrictive and inÍlammatory mediators
plays an impoilanl role. Masl cells, canying antigen-specific immunoglobulins
on their surface, are prominenl candidates for lhe produclion of lhese mediators
in the acute allergic (anaphylactic) reactions of patients. These immunoglobulins
consist in humars mainly of IgE, but in guinea-pigs the natural response lo
aclive sensitization consists mainly of IgG anlibodies, which adhere to mast cells
as well. However, by using a di-fferent adjuvant and a modified sensitization
procedure, we were able lo induce a shifl to IgE production in lhese animals,
reflecling lhe human situalion more closely. In isolaled human airways, obtained
at surgery fot lung cancel, IgE antibodies were applied by passive sensitization,
i.e. incubalion wilh human serum conlaining anligen-specifc immunoglobulins.
Airway lissues from IgG- and lgE-responding guinea-pigs and lgEJoaded
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release and to analyse in delail the subsequent smoolh muscle conlraclion
as well as the p-adrenergic inhibition of these responses. A main topic in
these investigations was the differentiation belween the interactions of lhe
p-adrenoceplor agonisl wilh the allergic mediators histamine, proslaglandin E2
(PgEz), and Ieukolrienes C+,D+,Ea s regalds (/) inhibition of mediator release,
(2) ftrnctional antagonism and synergism of lhe individual mediators and the
p-agonisl, and (3) medialor involvement in desensitizalion of the p-adrenoceptor.
A mah problem was lhe complexily of medialor inleractions, also in isolated
airways. In some cell systems, hislamine and leukotrienes are known to generate
proslanoids, whereas PgE2 can potenlially inhibil lhe release of histamine and
leukotrienes. Smooth muscle preparatiors are conlÍacted by histamine and
leukolrienes, whereas PgE2 can both act as a contractile and a relaxant agonisl.
This complexily is lirsl recognized in chapler 4, which describes a pilot study,
in which the allergic smooth muscle contraction of IgG- and lgE-sensitized
guinea-pigs and the p-adrenergic inhibition was modulated by step-wise
addition of selective medialor anlagonists.
In chapler 5 we observed thal IgE- compared with lgG-sensitized guinea-pig
airway lissues released significanlly more histamine. This release was shorlJasting
(less than 15 min). In addilion, lhe lgE-medialed histamine release was found
less sensitive to p-adrenergic inhibition lhan lhat of lgG-sensitized lung. This
difference was nol caused by lhe gÍeateÍ quantities of histamine release per se,
wNch could have explained the requirement of a stronger p-adrenoceptor
activition. The difierential p-adrenergic inhibition of antigen-induced histamine
release could be moddated with the leukotriene-receptor antagonist FPL5572
and the PgEe (EPr-leceptor) antagonist SCI922O, respectively and with the
cyclooxygenase inhibilor indomethacin. The resulls indicated lhat facilitalion
of lhe histamine release by endogenous leukotrienes or PgEz (irnportant in
IgE-sensitized lung) as well as inhibition via other prostanoid (EPz-) receplors
(most prominenl in IgG-sensitized lung) may explain the quanlitative difference
between IgE- and lgG-mediated histamine release and the difierential
p-adrenergic inhibition.
Chapter ó focused on the optimization of the conditions to study histamine
release. The batch-wise procedure used in chapler 5 was compared with a
novel superftrsion sel-up. It was found that (/) the quantitalive difierence
between IgE- and lgG-mediated histamine release during superftsion of
guinea-pig lung lissue was much greater than the difference oblained wilh
batch incubations, (Z) tne fissues were more sensitive to p-adrenergic inhibition
during superfusion, whereas the p-agonisl also discriminated more clearly
between IgE- and lgG-mediated release, and (3) preincubation of the tissues
al 0"C abolished the quanlilative difierence belween IgE- and lgG-mediated
histamine release as well as the difierential p-adrenergic inhibition. A reduced
accumulalion of modulatory mediators during superfirsion is regarded as a
mairr possible explanation of lhese results. A trigger for the non-specific release
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of such medialors might be temperatue changes during tissue handling,
palticularly relevant with balch-wise experiments. Data obtained using tracheal
tissue supporl the nolion that cartilage may have conlribuled to this release.
In chaplers 7, 8, and 9, IgE- and lgG-sensitized guinea-pig tracheal tissues
have been analyzed for the p-adrenergic inhjbition of antigen-induced smooth
muscle conlractions and for the release of Nslamine, leukolrienes, and PgE2.
Superfused lgE-sensilized lung tissue released much more leukotrienes upon
anligen challenge than lgG-sensilized lissue, in both Gases the release was
rapid and shorl lasting. In contrasl, lhe release of PgEz frorn superft:sed tracheal
rings was similar and long lasling. Delailed concenlralion-response studies wilh
fenolerol under various condilions (chapler Z) indicated that contraclile and
synergislic aclivities of leukolrienes and PgE2 are responsible for lhe reduced
p-adlenergic inhibition by fenolerol of IgE- compared with lgG-mediated
tracheal smooth muscle contractions.
Further analysis of lhe role of endogenous PgE2 bhapter 8) showed that
lhis plostaglandin contributed lo IgE- and lgG-mediated responses both by
contraclile (via EPr-receptors) and relaxant (via EPz-receplors) effects on airway
smooth muscle. Indomelhacin potentiated bolh the IgE- and lgG-mediated
contraction wilhout increasing leukotriene release. The EPr-receplor antagonist
SCI922O parlly diminished the contractions and increased the inhibition by
fenolerol. These effecls were abolished by indomethacin, whereas the inhibilion
by lhe leukotriene antagonist FPL557I2 was nol modulaled. The effects of
indomelhacin were complelely reslored by exogenous PgE2 in a concentralion
that did not modify lhe anaphylactic contraclion.
The results showed that, allhough similar amounls of PgEz were released
during IgE- and lgG-mediated contraclions, the prostaglandin played a
differential role in modulaling the two responses. The high lgE-mediated
leukotriene release completely ovem:led the relaxanl properties of PgEz, wNch
consequently only contributed lo some exlenl as a conlractile agonisl. However,
the relaxanl aclivily of the prostaglandin was clearly displayed in the presence
of FPL557I2 or SCI922O and the p-adrenergic inhibition was potentiated under
these conditions. In contrast, the conlraclions of lgG-sensitized tracheal muscle
were less dominated by leukotrienes, resulting in a highel sersilivity to
p-adrenergic inhibition which was nol potentiated by FPL557I2 or SCI922O.
ln Chapter 9 lhe queslion was addressed whelher the massive amount of
histamine, released during the early phase of the anaphylactic response,
secundarily modulales the release of Ieukotrienes and PgEz. The histamine
Hr-receptor anlagonist mepyramirre clearly inhibited PgEz release without
modulating the release of leukotrienes, indicaling lhat paÍl of the generation of
PgE2 was secundarily induced by endogenous histamine. Analysis of the
lime-cotuses of lhe anaphylaclic contraclions in lhe presence of mepyramine
and different mediator antagonisls conÍrmed lhe importance of this PgE2 pool




























r obtained using lracheal
lribuled lo this release.
uinea-pig tracheal tissues
f antigen-induced smooth
r, leukotrienes, and PgE2.
r more leukotrienes upon
h cases lhe release was
2 from superfrrsed tracheal
rtion-response studies wilh
;ated that conlraclile and
sponsible for the reduced
pared wilh lgG-mediated
1 (chapter 8) showed that
lialed responses bolh by
;ceptors) effects on airway
e IgE- and IgG-mediated
he EPr-receplor antagonist
creased the inhibition by
rcin, whereas the inhibition
modulated. The effects of
trs PgEz in a concentration
tls of PgEz were released
prostaglandin played a
;. The high lgE-mediated
t properties of PgEz, which
rntractile agonisl. However,
displayed in lhe presence
ion was potentialed under
.sersitized tracheal muscle
n a higher sensitivily to
r FPL557D or SCI922O.
rer the massive amount of
re anaphylactic response,
and PgEz. The hislamine
ed PgEz release withoul
rt parl of lhe geneÍation of
rislamine. Analysis of lhe
I presence of mepyramine
poÍlance of this PgE2 pool
j-mediated smooth muscle
conuaclion bul nol of lhe lgE-mediated and leukotriene-dominaled response.
Thus, paladoxical eífecls of mediator antagonists can be obtained in allergic
conlraclion' on lhe one hand, blockade of contraclile activities of medialors
can enhance endogenous (PgEz) and p-adrenergic inhibition of lhe Íesponse;
on lhe other hand, blockade of the contractile receptors can also affect the
secundary release of mediators like PgE2, possibly reducing endogenous
feed-back as well. Figure I shows a scheme of the proposed interactions,
derived ftom chaplers 7 to 9.
Fígure I
Proposed interactions and receptors
invoived in p-adrenergic inhibition
of allergic responses of airway
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11op-agonist 5 ahway smooth muscle relaxation
An additional faclor involved in the reduced p-adrenergic inhibition of
IgE-mediated airway smooth mtucle conlractiors, compared wilh IgG, cottld
have been helerologous desensitizalion of the p-adrenoceptors by the
anaphylactic mediators. The dala presented in chapter /O support this possibility.
Afler óO min of antigen-hdrrced contraction in lhe absence of lhe Ê-agonisl
and óO min of subsequent washing of lhe lracheal smoolh muscle, we obtained
a similar polency of fenolerol lo relax IgE- and IgG-medialed smooth mtrscle
conlractions. This implied that the excessive lgE-mediated release of contractile
medialors had not affected the p-adrenoceploÍs. However, if as little as 3 nM
fenoterol had been pÍesenl during the óO min of antigen challenge, approximately
4 limes higher fenoterol concenlralions were required to relax lhe smoolh
muscle tone of lgE-sensitized tissue. This reduclion of p-adrenoceptot sensitivity
could be prevenled wilh eithel FPL5572 or SCl9220 and was marginal Íct
IgG-sensitized tissue. Apparently, the activated p-adrenoceptors were desensitized
EPz
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by the synergislic aclion oí endogenous
duing antigen challenge, suggesting lhat
relaxant receplors was involved.
leukolrienes and PgEz generated
cross-talk of the contractile and
The final chapler // addressed a possible synergy of p-adlenoceptor agonisls
and cAMP phosphodiesterase (PDE) inhibitors in the inhibition of antigen-induced
responses of guinea-pig pelipheral lung and human small bronchi. In order to
discriminate between the roles of the non-regulaled isozyme (PDE IV) and lhe
cGMP-inhibiled isozyme (PDE III) of cAMP PDE, we used lhe inhibilors milrinone
(PDE IX selective), rolipram (PDE IV selective), Org3OO29 (a dual PDE IIIIN
inhibitor), and IBMX (non-selective).
The relaxant properlies of these PDE inhbilors and of fenolerol were very
similar for non-sensilized guinea-pig and human airways conlracted with a
moderalely active concenlralion of hislamine. However, lhe PDE inhibitors at
concentratiors lhat relaxed non-sensitized smoolh muscle conlraction by 5Of
or mole, were virlually inactive againsl antigen-induced contractions of actively
(lgE-) sensitized guinea-pig or passively sersitLed human airway smooth muscle.
Fenolerol was effective and inhibited lhe anaphylactic conlraclions of human
bronchi al much lower concenlralions lhan those of guinea-pig lung strip
preparations. At low-effeclive concentratiors of fenolerol, lhe p-adrenergic
inhibilion was higNy polentialed by lhe PDE IV selective and non-seleclive
inhibilors in both tissues. whereas the selective PDE III inhibitor milrinone
remained inactive.
Also the p-adtenergic inhibition of antigen-induced histamine release ftom
guinea-pig lung slices was potentiated by the seleclive PDE IV inhibitor. The
results showed thal inhibilion of the PDE [V isoenzyme seleclively polenliated
the p-adrenergic suppression of the allergic conlraction of sensilized human
and guinea-pig peripheral airways. This pronounced synergism is rather due
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